The effect of intravenous quinaprilat on plasma cytokines and hemodynamic variables during cardiac surgery.
D000804:Angiotensin II / Q000097:blood / Q000187:drug effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000097:blood / Q000494:pharmacology*; D002302:Cardiac Output / Q000187:drug effects; D001026:Coronary Artery Bypass; D016207:Cytokines / Q000097:blood*; D004311:Double-Blind Method; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D053590:Interleukin 1 Receptor Antagonist Protein; D016753:Interleukin-10 / Q000097:blood; D007552:Isotonic Solutions / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012795:Sialoglycoproteins / Q000097:blood / Q000187:drug effects; D012965:Sodium Chloride / Q000008:administration & dosage; D044005:Tetrahydroisoquinolines / Q000097:blood / Q000494:pharmacology*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D016207:Cytokines; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D007552:Isotonic Solutions; D012795:Sialoglycoproteins; D044005:Tetrahydroisoquinolines; D014409:Tumor Necrosis Factor-alpha; D000804:Angiotensin II; D016753:Interleukin-10; C054501:quinaprilat; D012965:Sodium Chloride